10-Q Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0000950170-25-067004`
Period End Date	20250331
Filing Date	20250508
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	tmdx-20250331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 150 Income Statement 68 Cash Flow Statement 130 Stockholders Equity 36 Comprehensive Income 16

Balance Sheet 150 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash	`Cash`	$310.14M	USD	Point-in-time
Cash	`Cash`	$310.14M	USD	Point-in-time
Cash	`Cash`	$350.22M	USD	Point-in-time
Cash	`Cash`	$350.22M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$336.65M	USD	Point-in-time
Cash	`Cash`	$336.65M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$142.03M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$142.03M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$97.72M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$97.72M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventory	`InventoryNet`	$43.38M	USD	Point-in-time
Inventory	`InventoryNet`	$43.38M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Inventory	`InventoryNet`	$46.55M	USD	Point-in-time
Inventory	`InventoryNet`	$46.55M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.29M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.29M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.37M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.37M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$497.22M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$497.22M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$505.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$505.92M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	33.62M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	33.62M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	33.83M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	33.83M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	33.62M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	33.62M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	33.83M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	33.83M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$285.97M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$285.97M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$311.24M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$311.24M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.48M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.48M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.01M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.01M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Goodwill	`Goodwill`	$11.55M	USD	Point-in-time
Goodwill	`Goodwill`	$11.55M	USD	Point-in-time
Goodwill	`Goodwill`	$11.55M	USD	Point-in-time
Goodwill	`Goodwill`	$11.55M	USD	Point-in-time
Acquired intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.10M	USD	Point-in-time
Acquired intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.10M	USD	Point-in-time
Acquired intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.15M	USD	Point-in-time
Acquired intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.15M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$211.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$211.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$208.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$208.00K	USD	Point-in-time
Total assets	`Assets`	$804.08M	USD	Point-in-time
Total assets	`Assets`	$804.08M	USD	Point-in-time
Total assets	`Assets`	$837.53M	USD	Point-in-time
Total assets	`Assets`	$837.53M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.29M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.29M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$40.14M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$40.14M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$45.15M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$45.15M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.74M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.74M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$2.08M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$2.08M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.73M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.73M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.79M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$55.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$55.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.91M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$449.94M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$449.94M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$450.65M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$450.65M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$59.37M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$59.37M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$59.45M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$59.45M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$6.25M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$6.25M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$5.52M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$5.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$571.22M	USD	Point-in-time
Total liabilities	`Liabilities`	$571.22M	USD	Point-in-time
Total liabilities	`Liabilities`	$575.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$575.47M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 33,827,880 shares and 33,617,972 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively.	`CommonStockValue`	$697.21M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 33,827,880 shares and 33,617,972 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively.	`CommonStockValue`	$697.21M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 33,827,880 shares and 33,617,972 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively.	`CommonStockValue`	$709.19M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 33,827,880 shares and 33,617,972 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively.	`CommonStockValue`	$709.19M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-327.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-327.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-364.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-364.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-468.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-468.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-442.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-442.56M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$137.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$137.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$266.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$266.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$159.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$159.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$228.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$228.60M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$804.08M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$804.08M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$837.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$837.53M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$143.54M	USD	1 Quarter
Total revenue	`Revenues`	$143.54M	USD	1 Quarter
Total revenue	`Revenues`	$96.85M	USD	1 Quarter
Total revenue	`Revenues`	$96.85M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$36.89M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$36.89M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$55.31M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$55.31M	USD	1 Quarter
Gross profit	`GrossProfit`	$59.96M	USD	1 Quarter
Gross profit	`GrossProfit`	$59.96M	USD	1 Quarter
Gross profit	`GrossProfit`	$88.23M	USD	1 Quarter
Gross profit	`GrossProfit`	$88.23M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$17.16M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$17.16M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$11.38M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$11.38M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$43.62M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$43.62M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$36.16M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$36.16M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$47.54M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$47.54M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$60.78M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$60.78M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$27.44M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$27.44M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$12.42M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$12.42M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.46M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.46M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.60M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.60M	USD	1 Quarter
Interest income and other income (expense)	`InterestIncomeAndOtherIncomeExpense`	$3.57M	USD	1 Quarter
Interest income and other income (expense)	`InterestIncomeAndOtherIncomeExpense`	$3.57M	USD	1 Quarter
Interest income and other income (expense)	`InterestIncomeAndOtherIncomeExpense`	$2.69M	USD	1 Quarter
Interest income and other income (expense)	`InterestIncomeAndOtherIncomeExpense`	$2.69M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-28.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-28.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-767.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-767.00K	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$12.39M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$12.39M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$26.68M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$26.68M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$196.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$196.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$994.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$994.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$25.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$25.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Net income per share, basic	`EarningsPerShareBasic`	$0.37	USD	1 Quarter
Net income per share, basic	`EarningsPerShareBasic`	$0.37	USD	1 Quarter
Net income per share, basic	`EarningsPerShareBasic`	$0.76	USD	1 Quarter
Net income per share, basic	`EarningsPerShareBasic`	$0.76	USD	1 Quarter
Net income per share, diluted	`EarningsPerShareDiluted`	$0.35	USD	1 Quarter
Net income per share, diluted	`EarningsPerShareDiluted`	$0.35	USD	1 Quarter
Net income per share, diluted	`EarningsPerShareDiluted`	$0.70	USD	1 Quarter
Net income per share, diluted	`EarningsPerShareDiluted`	$0.70	USD	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.76M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.76M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	33.72M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	33.72M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	34.68M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	34.68M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.91M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.91M	shares	1 Quarter

Cash Flow Statement 130 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$25.68M	USD	1 Quarter
Net income	`ProfitLoss`	$25.68M	USD	1 Quarter
Net income	`ProfitLoss`	$12.20M	USD	1 Quarter
Net income	`ProfitLoss`	$12.20M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$6.14M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$6.14M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.30M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$4.30M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.87M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.87M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$8.96M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$8.96M	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$772.00K	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$772.00K	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$787.00K	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$787.00K	USD	1 Quarter
Non-cash lease expense	`NonCashLeaseExpense`	$474.00K	USD	1 Quarter
Non-cash lease expense	`NonCashLeaseExpense`	$474.00K	USD	1 Quarter
Non-cash lease expense	`NonCashLeaseExpense`	$321.00K	USD	1 Quarter
Non-cash lease expense	`NonCashLeaseExpense`	$321.00K	USD	1 Quarter
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$573.00K	USD	1 Quarter
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$573.00K	USD	1 Quarter
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-199.00K	USD	1 Quarter
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-199.00K	USD	1 Quarter
Loss on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$-80.00K	USD	1 Quarter
Loss on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$-80.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$44.13M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$44.13M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$18.41M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$18.41M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-2.00M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-2.00M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$5.61M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$5.61M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.58M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.58M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.93M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.93M	USD	1 Quarter
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$24.00K	USD	1 Quarter
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$24.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$781.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$781.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.04M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.04M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-49.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-49.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-4.64M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-4.64M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$108.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$108.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$330.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$330.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-496.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-496.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-664.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-664.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.44M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.44M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.85M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.85M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.17M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.17M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.04M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.04M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.17M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.17M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-27.04M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-27.04M	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.55M	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.55M	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.74M	USD	1 Quarter
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.74M	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$1.29M	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$1.29M	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$638.00K	USD	1 Quarter
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$638.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.19M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.19M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.03M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.03M	USD	1 Quarter
Effect of exchange rate changes on cash and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$358.00K	USD	1 Quarter
Effect of exchange rate changes on cash and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$358.00K	USD	1 Quarter
Effect of exchange rate changes on cash and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-173.00K	USD	1 Quarter
Effect of exchange rate changes on cash and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-173.00K	USD	1 Quarter
Net decrease in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-44.59M	USD	1 Quarter
Net decrease in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-44.59M	USD	1 Quarter
Net decrease in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-26.51M	USD	1 Quarter
Net decrease in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-26.51M	USD	1 Quarter
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$310.64M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$310.64M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$350.72M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$350.72M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.15M	USD	Point-in-time
Cash and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.15M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$310.64M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$310.64M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$350.72M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$350.72M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.15M	USD	Point-in-time
Cash and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.15M	USD	Point-in-time
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.27M	USD	1 Quarter
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.27M	USD	1 Quarter
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.22M	USD	1 Quarter
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.22M	USD	1 Quarter
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.14M	USD	1 Quarter
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.14M	USD	1 Quarter
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.18M	USD	1 Quarter
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.18M	USD	1 Quarter
Cash	`Cash`	$310.14M	USD	Point-in-time
Cash	`Cash`	$310.14M	USD	Point-in-time
Cash	`Cash`	$350.22M	USD	Point-in-time
Cash	`Cash`	$350.22M	USD	Point-in-time
Cash	`Cash`	$336.65M	USD	Point-in-time
Cash	`Cash`	$336.65M	USD	Point-in-time
Restricted Cash	`RestrictedCash`	$500.00K	USD	Point-in-time
Restricted Cash	`RestrictedCash`	$500.00K	USD	Point-in-time
Restricted Cash	`RestrictedCash`	$500.00K	USD	Point-in-time
Restricted Cash	`RestrictedCash`	$500.00K	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$310.64M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$310.64M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$350.72M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$350.72M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.15M	USD	Point-in-time
Total cash and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$337.15M	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$137.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$137.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$266.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$266.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$159.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$159.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$228.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$228.60M	USD	Point-in-time
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.74M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.74M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.55M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.55M	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.29M	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.29M	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$638.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$638.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$8.96M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$8.96M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$6.87M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$6.87M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$17.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$17.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$37.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$37.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$25.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$25.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Balance	`StockholdersEquity`	$137.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$137.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$266.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$266.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$159.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$159.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$228.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$228.60M	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$25.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$25.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$17.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$17.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$37.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$37.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$37.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$37.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$17.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$17.00K	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$12.21M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$12.21M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$25.72M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$25.72M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.